Compare DigitalOcean Holdings Inc (DOCN) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DigitalOcean Holdings Inc vs Novo Nordisk A/S — how do they compare? DigitalOcean Holdings Inc trades at $119 (market cap $13.18B), while Novo Nordisk A/S trades at $50.94 (market cap $214.94B). The key difference: Novo Nordisk A/S is far larger — about 16.3× DigitalOcean Holdings Inc's market cap, and Novo Nordisk A/S pays a 3.67% dividend while DigitalOcean Holdings Inc pays none. Which is the better fit depends on your goals.
| DOCN | NVO | |
|---|---|---|
Market Cap | $13.18B | $214.94B |
Sector | Technology | Health |
52-Week High | $181.29 | $71.70 |
52-Week Low | $25.74 | $35.29 |
Enterprise Value | $13.74B | $233.91B |
Dividend Yield | — | 3.67% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DigitalOcean Holdings Inc
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and other countries.
Read more on DOCN →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
